Cat.#: ASSD-149
| Description | D-luciferin sodium salt, a water-soluble chemiluminescent luciferase substrate, is commonly used for in vivo and in vitro imaging of the expression of luciferase. The compound is nontoxic and stable in cells and live animals. |
| Size | 10 mg, 50 mg, 100 mg |
| Chemical Name | (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid sodium salt |
| Molecule Weight | 302.3 |
| Molecular formula | C11H7N2NaO3S2 |
| CAS Number | 103404-75-7 |
| PubChem identifier | 5702588 |
| MDL Number | MFCD00044938 |
| Purity | >98% |
| Solubility | Soluble in water (100 mM), and in DMSO (100 mM) |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-208 | NBD-X, succinimidyl ester (AC208) | 100 mg | inquiry |
| ASSD-143 | Fluorescently labeled Muscimol TMR-X conjugate (AC143) | 1mg | inquiry |
| ASSD-176 | Rhodamine B isothiocyanate (AC176) | 100 mg, 500 mg | inquiry |
| ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
| ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
| ASSD-225 | Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) | 10 mL | inquiry |
| ASSD-224 | Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) | 10 mL | inquiry |
| ASSD-221 | Antifade Fluorescence Mounting Medium with DAPI (hard set) (AC221) | 10 mL | inquiry |
| ASSD-109 | Picro Sirius Red Solution (AC109) | 250 mL | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.